Breaking Business News | Breaking business news AM | Breaking Business News PM

COVID-19 drug remdesivir will cost as much $3,120 in the United States

29 Jun 2020

Gilead Sciences has released how much it’s going to charge for its COVID-19 drug remdesivir—and it’s not cheap.

Gilead Sciences has released how much it’s going to charge for its COVID-19 drug remdesivir—and it’s not cheap.


Read the full article here.
This content was originally published by Fast Company. Original publishers retain all rights. It appears here for a limited time before automated archiving. By Fast Company

Covid-19 – Johns Hopkins University

Download brochure

Introduction brochure

What we do, case studies and profiles of some of our amazing team.

Download